ABSTRACT
O
ver the past three decades, asthma problems have increased considerably worldwide, which leads to disability and the use of maximum health resources of a country. The risk of disease occurs due to interactions between more than 100 susceptibility genes and multiple environmental factors. 1, 2 Asthma has strong genetic components, because its heritability has been estimated to vary from 40% to 60%. 3 Thus, it is important to identify the gene variants that play important role in the pathogenesis of asthma. Although interleukin (IL)-13 gene is studied extensively and found to be associated with asthma, IL13R␣1 association with asthma is still not well characterized.
The Th2 cells secrete various cytokines, such as IL-4, IL-5, IL-6, IL-9, IL-13, that are important regulator of inflammatory immune responses contributing atopy and immunity to parasites. 4 IL13 is directly involved in total immunoglobulin E (IgE) secretion by stimulating B cells. 5 It contains two receptors, IL13R␣1 and IL13␣2, 6 and IL13R␣1 is a 65-to 70-kDa glycosylated protein that binds to IL13 along with IL4R␣, which initiates signal transduction that results in mucin secretion, airway hyperreactivity, fibrosis, and chitinase up-regulation, which increases asthma risk. 7, 8 IL13R␣1 is expressed on nearly every cell, except human T cells. 9 The definite roles of IL13R␣1 in the IL13 signaling and response are still not very clear. Recent study conducted on a mouse model establishes the critical role of IL13R␣1 in aeroallergen-induced mucous secretion, IgE production, and eosinophil recruitment through chemokines production, which leads to the development of the disease. 10 The human IL13R␣1 gene is located on the chromosome Xq24. Because IL13s play a central role in the pathogenesis of asthma, 4,5 the genetic variation in their receptors may also leads to the development of the asthma severity. Structure analysis found that the IL13R␣1 gene contains 88-bp coding sequence followed by 13-kbp intron and ϩ1398A/G polymorphism lies in the noncoding region of IL13R␣1, which is associated with the increased IgE levels.
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Literature refers very few studies conducted on the role of ϩ1398A/G polymorphism in asthma phenotypes. 12 We are the first to report the impact of IL13R␣1 polymorphism in the pathogenesis of asthma in the North Indian population.
MATERIALS AND METHODS

Ethical Clearance
This study was conducted after receiving ethical clearance from Ethics Committee, Postgraduate Institute of Medical Education and Research, Chandigarh, India, vide Approval Memo No. PG-1Trg-10 on 9/21/2010. After doctors' diagnosis and the patients who fulfilled the criteria of Global Initiative for Asthma, guidelines were recruited for the study.
Inclusion/Exclusion Criteria
Recruitment of patients for this study are from different states of North India, including Chandigarh, Asthma patients with any other history of respiratory illness like chronic obstructive pulmonary disease, tuberculosis, pneumonia, or bronchitis were excluded in this study. Apart from these, any other comorbid illness such as diabetes mellitus, hypertension, or pregnant females were also excluded as cases from this study.
Pulmonary Function Test
Spirometry measures several aspects of lung function that are important in determining both the severity and prevention of asthma. Spirometry tests were performed strictly in accordance with the Association of Respiratory Technician and Physiologists guidelines 13 for generating pneumotachographs, helpful in assessing conditions such as asthma, chronic obstructive pulmonary disease, etc. using device Spiro 233 (PK Morgan, Rainham, Kent, United Kingdom). Out of 481 asthma patients, spirometry was done in 377 asthmatics, and the frequency of mild obstruction and AA genotype was found to be higher in the studied population.
Allergy Screening Tests
Allergic diseases, including asthma, are characterized by an increase of total IgE levels. It initiates and propagates the inflammatory cascade that leads to allergic responses in asthma. Total IgE was measured using ImmunoCAPs with device Phadia 100 IDM version 5.43 (Thermo Fisher Scientific Inc.) in serum samples of both control and asthma patients to screen allergy. Skin Prick Test and serum-specific IgE against Aspergillus fumigatus were also done and only negative Skin Prick Test patients with specific IgE less than 0.35 KUA/L were recruited in the study (Table 1) . Certain allergens (cow's milk, peanut, wheat, molds, pollens, pet dander, dust mite, etc.) are diluted and applied with a prick using a very thin needle on the surface of the skin (intradermal). After 15 minutes, the area of the skin was observed to see the reaction. If a raised, red, itchy bump develops, it indicates the presence of the allergy antibody. The larger the bump, the greater the sensitivity for that allergen in the individual.
The usually accepted upper limit is between 150 and 300 IU/mL, but it can range from 150 to 1000 IU/mL. 
Body Mass Index (BMI)
Increased BMI exaggerates the risk of acquiring asthma. BMI is a measure of human body shape based on an individual's weight and height, which indicate underweight (Ͻ18.5 kg/m 2 ), normal (18.5-24.9 kg/ m 2 ), overweight (25-29.9 kg/m 2 ), or obese (Ͼ30 kg/ m 2 ). Apart from this, weight (kg), height (cm), and body surface area were also provided.
Blood Sample Collection
Approximately 5-mL blood was taken in EDTAcoated vials for genomic DNA extraction using saline sodium citrate buffer method 16 and checked on 0.8% agarose gel by electrophoresis.
Genotyping
The amplification of the IL13R␣1 ϩ1398A/G polymorphism was done using polymerase chain reactionrestriction fragment length polymorphism method 17 using MseI (New England BioLabs, Hitchin, United Kingdom) (Fig. 1) . The primer sequences were: Forward 5Ј-TCAGTGATGGAGATAATTTA-3Ј and Reverse 5Ј-TGAGCTGCCTGTTTATAAAT-3Ј.
Statistical Analysis
All the statistical analyses were performed using the SPSS software version 20.0 (SPSS, Inc., Chicago, IL) and Epi Info version 3.4.7 (CDC, Atlanta, GA). 2 analysis was used to check the deviation from Hardy-Weinberg 
heterozygous AG genotype (130, 85, and 45 bp). Lane 3: homozygous mutant GG genotype (130 bp). Lane 4: homozygous wild AA genotype (85 and 45 bp).
equilibrium and to compare the genotype and allele frequency between asthma and control groups. Odds ratio (OR) and 95% confidence interval (CI) were used for the assessment of risk factors, and p Ͻ 0.05 was considered as statistically significant.
RESULTS
Study Population Characteristics
In the present study, IL13R␣1 ϩ1398A/G polymorphism was genotyped in a total of 964 subjects, including 483 healthy controls and 481 asthma patients. Apart from total IgE, other variables such as smoke exposure, family history, spirometry diagnosis, BMI, etc. were also examined, which has a significant role in asthma severity. The mean age for asthma patients was 37 years (range 18 -57 years), and age-matched healthy controls with mean age 34 years (range 18 -60 years) were compared (Table 1) . Mean disease duration was more than nine years in patients and 28% of asthmatic patients had a family history of asthma. Average of total IgE was higher in the asthmatics (2651.7 IU/mL) than the controls (776.1 IU/mL). Spirometry data were only available for asthma patients so we are unable to apply the statistics.
Prevalence of IL13R␣1 ؉1398A/G Polymorphism in the Indian Population
Comparing the statistical analysis of the results, it was found that the overall distribution of the wild A allele in IL13R␣1 ϩ1398A/G polymorphism has increased trends among the controls (61.8%) as compared with the asthmatics (57.4%), whereas the mutant G allele was slightly more prevalent among the asthmatics (42.7%) than in control subjects (38.2%), posing a significant risk toward asthma with OR ϭ 1.21, 95% CI (1.00 -1.45) and p ϭ 0.043 ( Table 2) .
The genotypic frequencies revealed that the homozygous wild AA genotype has increased frequency in the controls (44.3%) than in the asthmatics (39.1%) ( Table   2 ). The heterozygous genotype AG has increased trends among the asthmatics (36.4%) as compared with the controls (35.0%), and the homozygous mutant GG genotype has also increased frequency in the asthmatics (24.5%) than in the control subjects (20.7%) with nonsignificant p Ͼ 0.05.
Further categorizing the asthma patients based on the phenotypic characteristics of the disease (Table 3) , as obtained from their detailed proforma, such as sex (male/female), occurrence (seasonal/perennial), severity (wheeze on exertion/wheeze at rest), family history (positive/nil), rhinitis (positive/nil), allergy to at least two provoking factors (positive/nil), smoking status (nonsmoker/ever-smoker), long lasting cough for three to eight weeks (positive/nil), and pneumonia (childhood pneumonia/nil), statistical significant risk was found between IL13R␣1 ϩ1398A/G polymorphism and female sex with OR ϭ 1.32, 95% CI (1.04 -1.68) and p ϭ 0.019, perennial occurrence with OR ϭ 1.29, 95% CI (1.00 -1.66) and p ϭ 0.039, wheeze on exertion with OR ϭ 1.52, 95% CI (1.14 -2.03) and p ϭ 0.003, positive family history with OR ϭ 1.31, 95% CI (0.99 -1.74) and p ϭ 0.049, and patients without childhood pneumonia with OR ϭ 1.28, 95% CI (1.05-1.56) and p ϭ 0.014.
DISCUSSION
With the completion of the human genome project, the field of genetics has evolved over the past decade to better understand the function of the human genome, its regulation, and contribution of sequence variants to diseases. 18 To our knowledge, this is the first study to report the IL13R␣1 polymorphism as a risk factor toward asthma in the North Indian population. Using polymerase chain reaction-restriction fragment length polymorphism method, it was observed that the mutant G allele posing a significant risk toward asthma with significant p ϭ 0.043 (Table 2) . Although it is a weak association, some of the phenotypic 
